In cystic fibrosis (CF) HBE cells, pendrin mRNA expression and pHi are increased, whereas treatment with siRNA-pendrin decreases chloride/bicarbonate exchanger activity [25]. Here, SLC26A4 is linked to cystic fibrosis.